Navigation Links
Cardiac Science Increases R&D Capacity With 3-year Syncroness Agreement
Date:2/4/2009

BOTHELL, Wash., Feb. 4 /PRNewswire-FirstCall/ -- Cardiac Science (Nasdaq: CSCX), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, completed a three-year agreement for product design and engineering services from Colorado-based Syncroness, a leading design and engineering firm serving the medical devices industry.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH510LOGO)

"We expect considerable savings and speed-to-market improvements with Syncroness," said Bob Odell, vice president of engineering for Cardiac Science. The agreement increases Cardiac Science's engineering capacity to manage sustaining activities and new business opportunities. Odell adds, "This will allow seasoned Cardiac Science team members to focus on new customer solutions, revenue opportunities, and new advances in technology. As a result, we'll be even faster and more responsive to market needs."

"We've worked with Cardiac Science on a smaller scale and I can say they are a great partner," said chief marketing officer Jorg Lorscheider. "I'm confident we will reward Cardiac Science's trust with lowered costs, product development efficiencies, and an improved speed-to-market."

About Cardiac Science

Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AEDs), electrocardiograph devices (ECGs), cardiac stress systems and treadmills, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medica
'/>"/>

SOURCE Cardiac Science
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. The Sudden Cardiac Arrest Association Shoots Straight for the Heart
2. Experts Urge Limits on Use of Cardiac CT Scans
3. Proton pump inhibitors increase risk of heart attacks for patients on common cardiac drug
4. Easing regulations does not mean lower quality of cardiac care
5. New stretchable electrodes created to study stresses on cardiac cells
6. 2008 a Year of Growth and Unprecedented Service for The Larry King Cardiac Foundation
7. Cholesterol Levels May Not Measure Cardiac Risk
8. Newer Antipsychotics Pose Cardiac Risk: Study
9. Most heart attack patients cholesterol levels did not indicate cardiac risk
10. Penn study: Chances of surviving cardiac arrest depend on where patients are treated
11. Conference on cell therapy includes new session on stem cells for non-cardiac organ injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... (PRWEB) January 22, 2015 Payday lending ... vulnerable communities and cause financial distress to the states ... analysts at Howard University’s Center on Race and Wealth. ... in economic activity, payday loans at the same time ...
(Date:1/22/2015)... As interest in the value of spiritual support ... Rev. Eric J. Hall , president and CEO of ... be the keynote speaker on January 27 at an international ... , The conference, “Hope and Resilience: Innovative and Interdisciplinary Spiritual ...
(Date:1/22/2015)... Compare-autoinsurance.org has released a new blog post presenting a list of ... . , Some types of vehicles cannot be covered under ... blog post to see if their vehicle qualifies for auto insurance ... of the cars that cannot be covered by a plan. Clients ...
(Date:1/22/2015)... Richmond, VA (PRWEB) January 22, 2015 ... the power at the Science Museum of Virginia. Wicked ... 24. , Wicked Plants unearths 75 poisonous, carnivorous and ... traverse through each room to uncover the biochemical, physical ...
(Date:12/26/2014)... The US represents the largest market for CRC across the ... that sales of branded therapies were $2.23 billion. The US ... of the disease, high drug treatment rate, and higher drug ... of CRC therapies over the forecast period will be driven ...
Breaking Medicine News(10 mins):Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 3Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 4
... Researchers at the University Of Southern California, School Of ... bisphosphonates to increased jaw necrosis. The study is among ... common oral osteoporosis drugs may leave the jaw vulnerable ... the January 1 Journal of the American Dental ...
... Waltham, Mass.Everybody is familiar with the stereotypes of medical ... and even less glory. Now a novel Brandeis study ... back the curtain on the dominant environment of academic ... medical education in medical schools. , The study ...
... organ improved odds, study shows , , WEDNESDAY, Dec. 31 ... donated kidney raised the chances of a successful transplant ... European researchers report. , The study, published in the ... of Medicine , got generally favorable reviews from American ...
... of California, San Diego School of Medicine has identified ... enhances metastasis by stimulating the activity of inflammatory cells. ... issue of the journal Nature , explain how ... immune system to generate an inflammatory microenvironment hospitable for ...
... in, or past, menopause who use specially compounded "bioidentical" ... often don,t get adequate information from compounding pharmacists about ... one of the concerns about these medications addressed by ... ",Bioidentical, hormones: What you (and your patient) need to ...
... Strength Patches (12.5, 25, 75 and 100 mcg/hr) Not ... Ortho-McNeil-Janssen Pharmaceuticals, Inc., said today that one lot of ... sold by PriCara in the United States and one ... Inc. in the United States are being voluntarily recalled ...
Cached Medicine News:Health News:USC dentist links Fosomax-type drugs to jaw necrosis 2Health News:The culture of medicine 2Health News:A Better Method of Kidney Storage 2Health News:A Better Method of Kidney Storage 3Health News:Lung cancer cells activate inflammation to induce metastasis 2Health News:Women Using Compounded 'Bioidentical' Hormones Miss the Full Story About These Drugs 2Health News:PriCara(R) Recalls 50 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches 2Health News:PriCara(R) Recalls 50 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches 3
(Date:1/23/2015)... A lot of discussion in the medical community revolves ... injuries, or conditions. As medical science advances, doctors and surgeons ... that they consider to be more cutting edge. Yet, when ... method of treatment that stands out as the best solution ...
(Date:1/23/2015)... Biotherapeutics, Inc. (NASDAQ: NWBO )("NW Bio"), a U.S. ... inoperable solid tumor cancers, announced today that CEO Linda ... Phacilitate Immunotherapy Forum in Washington D.C. ... on January 26 at 10:30 a.m. EST at the Grand ...
(Date:1/23/2015)... , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( ... of directors of Advaxis, Inc. ("Advaxis" or the "Company") ... has breached its fiduciary duties to shareholders. ... an investing website reporting that Advaxis had misrepresented the ...
Breaking Medicine Technology:No One-Size-Fits-All Remedy for Hernia Correction 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2
... (CCRP) invites golfers to participate in its second annual,"Drive for ... Country Club,14601 Country Club Drive, Aurora. The private club is ... to major events such as the,Colorado Women,s Open. The club ... inducted into the Colorado Hall of Fame., By hosting ...
... 27 Calvin A. Grant, MD,Retina Macular ... case control study that was designed to ... ophthalmic solution) in Lucentis(R),(ranibizumab) treatment of choroidal ... an oral poster presentation at,the 2008 Annual ...
Cached Medicine Technology:Colorado Cancer Research Program Will Host Golf Event to 'Drive' the Message that Clinical Trials Play a Vital Role in the Quest to Find a Cure for Cancer 2Colorado Cancer Research Program Will Host Golf Event to 'Drive' the Message that Clinical Trials Play a Vital Role in the Quest to Find a Cure for Cancer 3Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) 2Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) 3Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) 4
Sera available in three levels for the control of accuracy and precision for up to 31 analytes...
Human based material available in two levels for the control of accuracy and precision for upto 23 analytes....
CRP Liquid Conrtols level 3...
The IRN method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of iron in serum....
Medicine Products: